Advertisement

Topics

Latest "Cobra Biomanufacturing" News Stories

13:10 EST 16th November 2018 | BioPortfolio

Here are the most relevant search results for "Cobra Biomanufacturing" found in our extensive news archives from over 250 global news sources.

More Information about Cobra Biomanufacturing on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cobra Biomanufacturing for you to read. Along with our medical data and news we also list Cobra Biomanufacturing Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cobra Biomanufacturing Companies for you to search.

Showing "Cobra Biomanufacturing" News Articles 1–25 of 142

Relevant

Amgen breaks ground on $200m biomanufacturing facility in US

The company expects to invest up to $200m in the approximately 120,000ft² biomanufacturing plant at its West Greenwich campus in Rhode Island. Amgen will use its next-generation biomanufacturing The post Amgen breaks ground on $200m biomanufacturing facility in US appeared first on Pharma Business review.


Amgen begins work on $200m ‘next-gen’ biomanufacturing site

Amgen has broken ground on the construction of its West Greenwich, Rhode Island-based 120,000-square-foot biomanufacturing facility.

Cobra Biologics Celebrates the Queen’s Award for Enterprise in International Trade

Cobra Biologics a leading international contract development and manufacturing organisation were presented with the Queen’s Award for Enterprise in International Trade 2018, by the Lord Lieutenant of Staffordshire on 20 September 2018. The prestigious award is in recognition of Cobra’s commercial success in providing services to its global customer base. Guests attending the event incl...


Amgen Breaks Ground On Next-Generation Biomanufacturing Plant In Rhode Island

The Plant Will be First-of-its-Kind in the U.S. THOUSAND OAKS, Calif., July 31, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the groundbreaking of its new next-generation biomanufacturing plant that will be constructed at its West Greenwich, R.I. campus. The new plant is the first-of-its-kind in the U.S. and will use Amgen's proven next-generation biomanufacturing capabilities to ma...

Cobra cannibalism more prevalent than previously thought

(Ecological Society of America) Researchers in South Africa's Kalahari Desert found a large male cape cobra devouring another smaller male of the same species. Surprised by the thought-to-be-rare event, they decided to investigate how common and widespread cannibalism was in cobras.

Biomanufacturing sector set to ‘boost its efficiency’

The next five years will see game-changing improvements made in upstream, downstream and continuous bioprocessing, predicts one industry specialist... The post Biomanufacturing sector set to ‘boost its efficiency’ appeared first on European Pharmaceutical Review.

Cobra Biologics Awarded with Bionow Project of the Year 2016

Celebrating the crème-de-la-crème of life sciences talent in the North of England and sponsored by Manchester Science Partnerships, the awards ceremony recognised the biomedical industry’s highest achievers. Around 400 people attended the gala dinner at The Mere Golf Resort and Spa, Cheshire, hosted by comedian and broadcaster Paul Sinha, one of the stars of the ITV quiz The Chase. The team at...

Series B equity financing round closes at €16 million to support development of biomanufacturing tech

Tech company, Univercells, and Global Health Investment Fund (GHIF) have announced the closing of a €16 million Series B equity financing round, which will support the continued development of Univercell’s biomanufacturing technology.

Cobra Biologics and The University of Manchester Announce Collaboration to Improve Industrial Scale-up

Keele and Manchester, UK, 24 September 2015: Cobra Biologics, international CDMO of biologics and pharmaceuticals, and Alan Dickson, Professor of Biotechnology at The University of Manchester (UoM) today announced a two year collaboration focused on improving understanding of cellular bioprocessing required for the scaled production of therapeutic proteins. The collaboration is supported via the F...

Therapure Biomanufacturing Announces U.S. ...

Read more...

Helping Clients Improve their Biomanufacturing Processes -- http://ow.ly/xKU830m6e8Y pic.twitter.com/aL0QkesJzD

Helping Clients Improve their Biomanufacturing Processes -- http://ow.ly/xKU830m6e8Y  pic.twitter.com/aL0QkesJzD

Helping Clients Improve their Biomanufacturing Processes -- http://ow.ly/B4an30m6e58 pic.twitter.com/VH2KgS5C2x

Helping Clients Improve their Biomanufacturing Processes -- http://ow.ly/B4an30m6e58  pic.twitter.com/VH2KgS5C2x

Partnership to develop cost effective regenerative medicine

Cobra Biologics, GE Healthcare and Centre for Process Innovation will collaborate to help advance gene therapy

Cobra Biologics, University of Leeds Receive Grant

£100K is to look into the effects of hydrodynamic force on the structure & biological integrity of viral vector gene therapy

University of Virginia Center for Advanced Biomanufacturing Charts Path Forward for Field of ...

Charlottesville, Va., Oct. 11, 2018 (GLOBE NEWSWIRE) Read more...

Cobra and Tecrea Awarded £112K Innovate UK Grant to Develop AAV Scalable Production Bioprocess

Cobra Biologics and Tecrea, a cell delivery biotechnology company, have been awarded a 15 month collaborative grant of £112,291 ($166,000 USD) by the UK’s innovation agency, Innovate UK for the development of a scalable Adeno Associated Virus (AAV) production bioprocess.The grant is awarded under Innovate UK’s ‘Technology Inspired Innovation’ competition, which aims t...

Cobra Biologics, GE, & CPI Enter Partnership

Three-way partnership funded by a £570K Innovate UK grant, to increase robustness & reduce costs for the mfg. of AAV vectors

Cobra & CPI to Collaborate on Regenerative Medicine

Cobra Biologics Ltd (Cobra), international CDMO of biologics and pharmaceuticals, and the Centre for Process Innovation (CPI), a UK-based technology innovation centre, are collaborating on a project which will focus on the development of an Industrial Manufacturing Platform for Adeno-Associated Virus (AAV) production to support gene therapy and regenerative medicine. The £1.8M project, which...

Advanced Therapies Manufacturing Taskforce

Cobra’s objective in the UK is to become a centre of excellence for the manufacturing of AMTs from pre-clinical to commercial supply. They already have a global reputation GMP manufacturing in this area and are looking forward to further expansion to commercial supply in this exciting and innovative sector.As you may be aware, Cobra Biologics has been intrinsically linked to Cell and Gene Th...

Alegeus and iTEDIUM Partner to Deliver Comprehensive COBRA Administration and Compliance

Partnership empowers Alegeus clients to deliver market-leading COBRA capabilities under their brand Alegeus, the market leader in consumer directed healthcare (CDH) solutions, and

Samsung looks to expand CDMO biz with $22bn investment

Samsung plans to invest KRW 180 trillion into its various businesses over the next three years, including in biomanufacturing-focused Samsung BioLogics.

DNA Script Awarded $2.7M in Innovation Grants From Bpifrance — Total Financing Raised to Date ...

This new grant will be dedicated to the development of the company’s platform for biomanufacturing long DNA constructs for cell and gene therapy applications Read more...

Cobra, Pfizer, GE Healthcare safe in Sweden fires

The dozens of âdevastating, unprecedented and dangerousâ forest fires raging across Sweden are far from manufacturing and industrial centres, says Swedish Association of the Pharmaceutical Industry.

WuXi Biologics says Ireland an attractive option post-Brexit, invests €325m

The Chinese CDMO says it will build a biomanufacturing facility in Ireland with single-use bioreactors and continuous bioprocessing capabilities.

Cobra Biologics and Symbiosis awarded £1.9m ($2.5m USD) Innovate UK Grant

Cobra Biologics, an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services, a contract manufacturing organisation (CMO) specialising in sterile Fill Finish, today announced that they have been awarded a 16-month collaborative grant of £1.9m from Innovate UK.The grant will position the partner companies ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks